TNPSC Thervupettagam

Smart Insulin for Diabetes

October 29 , 2024 32 days 207 0
  • Scientists have developed the “holy grail” diabetes treatments - a “smart” insulin that responds in real time to fluctuations in one’s blood sugar level.
  • The newly developed NNC2215 is effective as human insulin at lowering blood glucose in rats and pigs.
  • The engineered insulin requires a significant glucose spike to be activated, and once it is activated, there is a sudden rush of insulin in the system.
  • Type 1 diabetes, which often starts in childhood, occurs when the pancreas does not produce insulin (or enough insulin).
  • Type 2 diabetes sees the cells of the body develop resistance to insulin, meaning greater amounts are required that what is produced by the pancreas.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories